Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
October 2003
2003:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2004 | 2005 | 2006 | 2007 | 2008
News | News in brief | News Features
News
Democrats condemn government 'meddling' with NIH
The Bush administration's suggestion that thousands of NIH jobs might be contracted out to the private sector is drawing fire from Democrats in Congress.
Nature (30 October 2003)
| Full Text |
South Florida rocked as dean quits over political funding
Plans by the University of South Florida (USF) to enter the top league of US biomedical research institutions suffered another blow this month with the resignation of the dean of its medical school.
Nature (30 October 2003)
| Full Text |
Europe kills cash flow to EURESCO science meetings
A popular series of intimate, cutting-edge scientific meetings for European researchers is facing the axe because it doesn't fit the priorities of the European Union (EU) Framework programme of research.
Nature (30 October 2003)
| Full Text |
Open access wins German support
Germany's main scientific organizations have issued a joint statement backing initiatives that provide free scientific information over the Internet.
Nature (23 October 2003)
| Full Text |
Health chiefs poised to step up US scrutiny of microbe research
The United States is set to implement formal structures for dealing with biological research that could aid terrorists, in the light of recommendations issued by the National Academy of Sciences.
Nature (16 October 2003)
| Full Text |
Routine tests reveal unknown strains of BSE prions
New strains of the prion that causes bovine spongiform encephalopathy (BSE) have been reported by scientists in Italy and Japan.
Nature (16 October 2003)
| Full Text |
Biologists join physics preprint club
The ArXiv preprint server – physicists' favourite place for early circulation of their results – has branched out into biology.
Nature (9 October 2003)
| Full Text |
Mosquito production mooted as fast track to malaria vaccine
A leading US researcher is probing an audacious approach to develop a malaria vaccine by cultivating billions of parasites, irradiated to stop them causing disease, in swarms of live mosquitoes.
Nature (2 October 2003)
| Full Text |
NIH 'roadmap' charts course to tackle big research issues
The director of the US National Institutes of Health has announced a long-term plan for the biomedical research agency in which its component institutes will join forces to tackle priority projects.
Nature (2 October 2003)
| Full Text |
Harvard heralds fresh take on systems biology
Harvard Medical School is to set up a department devoted to systems biology – the first entirely new department to be founded at the institution in 20 years.
Nature (2 October 2003)
| Full Text |
Wellcome to fund publication in open-access journals
One of the world's largest research charities, the UK-based Wellcome Trust, has lent its support to calls for 'open access' to the scientific literature.
Nature (2 October 2003)
| Full Text |
China takes centre stage for liver proteome
China is set to lead a massive research project to describe all of the proteins in the human liver – the liver proteome.
Nature (2 October 2003)
| Full Text |
Diabetes treatments get sweet help from nature
Mexican shamans have a wealth of experience in treating 'sweet blood', a disease that affects the indigenous population in the highlands of Mexico at record rates.
Nature Medicine (October 2003)
| Full Text |
Bacterial battalions join war against cancer
Researchers battling cancer are finding an unexpected and powerful ally: bacteria. The idea is far from new–it was tried and abandoned years ago–but researchers are now resurrecting it with a modern twist.
Nature Medicine (October 2003)
| Full Text |
Parkinson pioneers blaze trail of controversy
Doctors at Weill Cornell Medical College in New York City injected virus particles, laden with a gene to dampen overwrought neurons, deep into Nathan Klein's brain. The aim: to rid him of Parkinson disease.
Nature Medicine (October 2003)
| Full Text |
Cancer patients sue for access to experimental drugs
A cancer advocacy group has filed a lawsuit against the US Food and Drug Administration in a bid to get experimental cancer drugs into the hands of patients who have exhausted approved treatments.
Nature Medicine (October 2003)
| Full Text |
Profile: Tak Mak
The only constant in Tak Mak's career has been change. After jumping from a Jesuit seminary to engineering, to immunology and genetics, the scientific vagabond says he has finally found his true passion.
Nature Medicine (October 2003)
| Full Text |
Increasing number of companies found ineligible for SBIR funding
Because of a tightening in the implementation of eligibility rules, a valuable source of US government funding for biotechnology companies is in jeopardy.
Nature Medicine (October 2003)
| Full Text |
News in brief
Foreign students to foot the bill for US security scheme
| NIH grant leads energy lab into protein project
| Top lab contracts awarded as US battles deadly bugs
| Search comes to an end as Cell fills editor's chair
| New stem cell lines created
| California rejects party line on stem-cell work |
News Features
Restless nights, listless days
More and more people's working and social lives are blighted by skewed sleep patterns. Is it time for the medical mainstream to take notice of what neuroscientists are learning about the body clock?
Nature (30 October 2003)
| Full Text |
Special section on human genetics: The rough guide to the genome
A new effort to map human genetic variation should provide a shortcut for researchers trying to uncover the roots of disease. Carina Dennis profiles the 'HapMap' project.
Nature (23 October 2003)
| Full Text |
Special section on human genetics: With your genes? Take one of these, three times a day
Truly 'personalized' medicine remains a distant goal. But researchers are now thinking about how to use genomic data to avoid prescribing drugs that may kill, or won't work. Alison Abbott reports.
Nature (23 October 2003)
| Full Text |
Scientific publishing: Who will pay for open access?
A new biology journal, positioned to compete with the likes of Nature, Science and Cell, aims to reinvent the economics of high-quality scientific publishing.
Nature (9 October 2003)
| Full Text |
Across the great divide
Scientists like to think that research collaboration can overcome political barriers. But for those on opposite sides of the Israeli–Palestinian conflict, how realistic is this ideal? Jim Giles visited the region to find out.
Nature (2 October 2003)
| Full Text |
|
